SV Atlas
← All founders
Jennifer Curtin

Jennifer Curtin

Co-founder & Chief Medical Officer @ RTHM Inc. (YCW22🍊)

Co-founderRTHM logoRTHM· Winter 2022🇺🇸 Redwood City, California, United States
2020Co-founder· RTHM, Inc.
Founder · since 2020
Company
RTHM, Inc.
Role
Co-Founder & CMO
current
Stage
—
no public source
Raised
—
no public source
Based
Redwood City, California, United States
current
Founder / co-founder — the company's markEmployee / research role
Source: LinkedIn work history
Profile coverage5 of 7 · missing posts, contact
RTHM logo
RTHM

Self-learning care for complex illness

Winter 2022

Experience

Career

  • RTHM, Inc. logo

    RTHM, Inc.

    Co-founder

    Co-Founder & CMO · Redwood City, California, United States · 2020 – Present

    2020
  • Center for Complex Diseases

    Physician · Mountain View, CA · 2019 – 2022

    2019
  • Jennifer Curtin, MD

    President · 2018 – 2019

    2018
  • Holtorf Medical Group logo

    Holtorf Medical Group

    Physician · El Segundo, California · 2016 – 2018

    2016
  • UC Irvine Medical Center logo

    UC Irvine Medical Center

    Resident Physician · 2013 – 2016

    2013
  • UC Irvine logo

    UC Irvine

    Research Associate · Irvine, California · 2014 – 2015

    2014
  • Genomics Institute Of The Novartis Research Foundation

    Research Associate (Temp) · La Jolla, California · 2008

    2008
  • Salk Institute for Biological Studies

    Research Associate · La Jolla, CA · 2006 – 2007

    2006
  • UT Southwestern

    Summer Research Fellow · Dallas, Texas · 2006

    2006
  • California Lutheran University

    Research Intern · Thousand Oaks, CA · 2004 – 2005

    2004

Bio

Physician treating post-viral illnesses & ME/CFS for >5 yrs, Long COVID for the past year. Member of the ME/CFS Clinician Coalition & co-author of the latest Coalition ME/CFS expert management guidance published in Mayo Clinic Proceedings 8/25/2021. Streamlined/mapped the complex decision making, testing & treatment logic for Long COVID & frequently diagnosed co-morbid illnesses (incl ME/CFS) so it can be more rapidly utilized by new healthcare providers and scaled.